-transparent.png){kind=logo}
The article "SOCS3 overexpression enhances ADM resistance in bladder cancer T24 cells, by M.-Z. Li, D.-H. Lai, H.-B. Zhao, Z. Chen, Q.-X. Huang, J. Situ, published in Eur Rev Med Pharmacol Sci 2017; 21 (13): 3005-3011-PMID: 28742207" has been withdrawn due to misunderstandings among some authors (Dr. Dehui Lai and Dr. Haibo Zhao) concerning the submission of the article. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/13067.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
M-Z Li, and
D-H Lai, and
H-B Zhao, and
Z Chen, and
Q-X Huang, and
J Situ
January 2015,
PloS one,
M-Z Li, and
D-H Lai, and
H-B Zhao, and
Z Chen, and
Q-X Huang, and
J Situ
April 1999,
British journal of cancer,
M-Z Li, and
D-H Lai, and
H-B Zhao, and
Z Chen, and
Q-X Huang, and
J Situ
February 2011,
Cancers,
M-Z Li, and
D-H Lai, and
H-B Zhao, and
Z Chen, and
Q-X Huang, and
J Situ
April 1998,
Zhonghua yi xue za zhi,
M-Z Li, and
D-H Lai, and
H-B Zhao, and
Z Chen, and
Q-X Huang, and
J Situ
May 2008,
Journal of cellular biochemistry,
M-Z Li, and
D-H Lai, and
H-B Zhao, and
Z Chen, and
Q-X Huang, and
J Situ
December 2012,
Bioelectrochemistry (Amsterdam, Netherlands),
M-Z Li, and
D-H Lai, and
H-B Zhao, and
Z Chen, and
Q-X Huang, and
J Situ
July 2016,
Oncotarget,
M-Z Li, and
D-H Lai, and
H-B Zhao, and
Z Chen, and
Q-X Huang, and
J Situ
January 2024,
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
M-Z Li, and
D-H Lai, and
H-B Zhao, and
Z Chen, and
Q-X Huang, and
J Situ
June 2021,
Nanomaterials (Basel, Switzerland),
M-Z Li, and
D-H Lai, and
H-B Zhao, and
Z Chen, and
Q-X Huang, and
J Situ
September 2014,
Biochemical pharmacology,
